Evidence map›Paper›PMID 25888510›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2015

PC-PLC/sphingomyelin synthase activity plays a central role in the development of myogenic tone in murine resistance arteries.

Joseph R H Mauban, Joseph Zacharia, Seth Fairfax, Withrow Gil Wier

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Potential Drug Targets for Ceramide Metabolism in Cardiovascular Disease.Journal of cardiovascular development and disease · 2022
    Review
  3. Review
  4. Review
  5. Review
  6. Voltage-gated CaAmerican journal of physiology. Heart and circulatory physiology · 2018
    Article
  7. Article
  8. STIM1 Knockout Enhances PDGF-Mediated CaInternational journal of molecular sciences · 2018
    Article
  9. Article
  10. Regional heterogeneity in the mechanisms of myogenic tone in hamster arterioles.American journal of physiology. Heart and circulatory physiology · 2017
    Article
  11. Review
  12. Calcium Channels in Vascular Smooth Muscle.Advances in pharmacology (San Diego, Calif.) · 2017
    Review
  13. Central Role of P2Y6 UDP Receptor in Arteriolar Myogenic Tone.Arteriosclerosis, thrombosis, and vascular biology · 2016
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Joseph R H MaubanDepartment of Physiology, School of Medicine, University of Maryland Baltimore, Baltimore, Maryland jmauban@umaryland.edu.
Joseph ZachariaDepartment of Physiology, School of Medicine, University of Maryland Baltimore, Baltimore, Maryland.
Seth FairfaxDepartment of Physiology, School of Medicine, University of Maryland Baltimore, Baltimore, Maryland.
Withrow Gil WierDepartment of Physiology, School of Medicine, University of Maryland Baltimore, Baltimore, Maryland.
University of Maryland, Baltimore · US

Funding

Physiological Regulation of MLCK in Intact ArteriesR01HL091969 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI WIER, WITHROW GIL · 2010 to 2013
$1.5M
NHLBI NIH HHS 5R01-HL-091969
6 · The paper itself

Abstract

Myogenic tone is an intrinsic property of the vasculature that contributes to blood pressure control and tissue perfusion. Earlier investigations assigned a key role in myogenic tone to phospholipase C (PLC) and its products, inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). Here, we used the PLC inhibitor, U-73122, and two other, specific inhibitors of PLC subtypes (PI-PLC and PC-PLC) to delineate the role of PLC in myogenic tone of pressurized murine mesenteric arteries. U-73122 inhibited depolarization-induced contractions (high external K(+) concentration), thus confirming reports of nonspecific actions of U-73122 and its limited utility for studies of myogenic tone. Edelfosine, a specific inhibitor of PI-PLC, did not affect depolarization-induced contractions but modulated myogenic tone. Because PI-PLC produces IP3, we investigated the effect of blocking IP3 receptor-mediated Ca(2+) release on myogenic tone. Incubation of arteries with xestospongin C did not affect tone, consistent with the virtual absence of Ca(2+) waves in arteries with myogenic tone. D-609, an inhibitor of PC-PLC and sphingomyelin synthase, strongly inhibited myogenic tone and had no effect on depolarization-induced contraction. D-609 appeared to act by lowering cytoplasmic Ca(2+) concentration to levels below those that activate contraction. Importantly, incubation of pressurized arteries with a membrane-permeable analog of DAG induced vasoconstriction. The results therefore mandate a reexamination of the signaling pathways activated by the Bayliss mechanism. Our results suggest that PI-PLC and IP3 are not required in maintaining myogenic tone, but DAG, produced by PC-PLC and/or SM synthase, is likely through multiple mechanisms to increase Ca(2+) entry and promote vasoconstriction.

Indexed as

Signal TransductionVascular ResistanceVasoconstrictionAnimalsArterial PressureCalcium SignalingDiglyceridesEnzyme InhibitorsMesenteric ArteriesMiceMuscle, Smooth, VascularPhosphatidylcholinesTime FactorsTransferases (Other Substituted Phosphate Groups)Type C PhospholipasesDiglyceridesEnzyme Inhibitorsphosphatidylcholine-ceramide phosphocholine transferasePhosphatidylcholinesphosphatidylcholine-specific phospholipase CTransferases (Other Substituted Phosphate Groups)Type C PhospholipasesBaylisscalciumdiacylglycerolphospholipase C

Identifiers

PMID25888510
PMCPMC4469871
OpenAlexW2140918170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.